PROTECTING THE U.S. PHARMACEUTICAL SUPPLY CHAIN: A PATH FORWARD

  • CMPI | by: Peter Pitts and Cathy McMorris Rodgers |
  • 02/03/2026 12:00 AM

The Urgency of an FDA Abraham Accords Office

How proactive FDA policies can help strengthen the American pharmaceutical supply chain of essential medicines, create jobs through increased domestic manufacturing, reward our global allies, and further support peace in the Middle East.

Peter J. Pitts

Senior Fellow, U.S. Israel Education Association
President, Center for Medicine in the Public Interest
Visiting Professor, University of Paris School of Medicine
Former Associate Commissioner, U.S. Food and Drug Administration

Cathy McMorris Rodgers

Congresswoman, Washington’s fifth congressional district, 2005-2025
Congressional representative to the United Nations General Assembly, 2019-2020
Co-Founder, Abraham Accords Congressional Caucus
Fellow, U.S. Israel Education Association

Executive Summary

Problem: Foreign nations are holding America’s medicine cabinets for ransom. Today there is the very real risk of drug shortages being caused, on purpose, by foreign governments for political goals that put American patients at risk.

Solution: On-shore when possible. Friend-shore where plausible.

The creation of an FDA Abraham Accords Office represents a pragmatic, forward-looking solution to one of the most pressing structural weaknesses in U.S. public health security: its dependence on fragile and opaque pharmaceutical supply chains in China and India.

We must extricate our medical supply chain from countries that could weaponize this
dependence, by manufacturing on our own shores when practical and shifting our foreign
partnerships from places like China to more friendly nations such as those of the Abraham
Accords. That’s called “Friend-Shoring,” relocating manufacturing capacity to trusted partners who share regulatory standards and political alignment.

The Abraham Accords nations — Israel, the United Arab Emirates, Bahrain, and Morocco — combine advanced health infrastructure, political stability, and shared strategic alignment with the United States. Establishing an FDA presence in the region transforms diplomatic goodwill into a tangible health-security architecture.

Click here for PDF
 
Sign Up for Our Email Newsletter

RECENT NEWS

We Can Fight Fraud Without Threatening Access to Care

We Can Fight Fraud Without Threatening Access to Care

When Washington fails to police its own programs, it’s hardworking Americans that pay the price. ...  Read more

Big Apple Hospital CEOs are Cooking the Not-for-Profit Hospital Books

Big Apple Hospital CEOs are Cooking the Not-for-Profit Hospital Books

There is something almost too neat—too polished—about the way not-for-profit hospitals tell their financial story. It is...  Read more

Modernizing North Carolina's Nonprofit Social Contract

Modernizing North Carolina's Nonprofit Social Contract

Nonprofit hospitals occupy a uniquely privileged position in the American healthcare system. Their exemption from federal...  Read more

DRUGWONKS BLOG